The perioperative management of patients undergoing combined heart-liver transplantation

Transplantation

Volumn 99, Issue 1, 2015, Pages 139-144

  Barbara, David W ^a   Rehfeldt, Kent H ^a   Heimbach, Julie K ^b   Rosen, Charles B ^b   Daly, Richard C ^b   Findlay, James Y ^c  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISATRACURIUM; FRESH FROZEN PLASMA; ISOFLURANE; NITRIC OXIDE; PANCURONIUM; PROSTAGLANDIN E1; VECURONIUM;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; DIALYSIS; ENDOTRACHEAL INTUBATION; FAMILIAL AMYLOIDOSIS; FEMALE; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY TRANSPLANTATION; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; NEUROMUSCULAR BLOCKING; OUTCOME ASSESSMENT; PATIENT CARE; PERIOPERATIVE PERIOD; PLASMA TRANSFUSION; PLASMAPHERESIS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; RIGHT VENTRICULAR ASSIST DEVICE; SURGICAL APPROACH; SURGICAL TECHNIQUE; THROMBOCYTE TRANSFUSION; TREATMENT INDICATION; COMPLICATION; HEART DISEASES; LIVER DISEASES; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; BLOOD TRANSFUSION; FEMALE; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; INTENSIVE CARE UNITS; KIDNEY TRANSPLANTATION; LENGTH OF STAY; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MINNESOTA; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84920110562     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000231     Document Type: Article

References (26)

1. Starzl TE, Bilheimer DW, Bahnson HT, et al. Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet 1984;1:1382.
2. Cannon RM, Hughes MG, Jones CM, et al. A review of the United States experience with combined heart-liver transplantation. Transpl Int 2012;25:1223.
3. Gandhi SK, Reyes J,Webber SA, et al. Case report of combined pediatric heart-lung-liver transplantation. Transplantation 2002;73:1968.
4. BarshesNR, Udell IW, JoyceDL, et al.Apooled analysis of posttransplant survival following combined heart-liver transplantation. Transplantation 2007;83:95.
5. DiazGC, Renz JF, Nishanian E, et al. Anesthetic management of combined heart-liver transplantation. J Cardiothorac Vasc Anesth 2007;21:253.
6. Nagpal AD, Chamogeorgakis T, Shafii AE, et al. Combined heart and liver transplantation: the Cleveland Clinic experience. Ann Thorac Surg 2013;95:179.
7. Faenza S, Arpesella G, Bernardi E, et al. Combined liver transplants: main characteristics from the standpoint of anesthesia and support in intensive care. Transplant Proc 2006;38:1114.
8. Eyraud D, Ben Menna M, Vaillant JC, et al. Perioperative management of combined heart-liver transplantation in patients with cirrhosis, renal insufficiency, or pulmonary hypertension. Clin Transplant 2011;25:228.
9. Befeler AS, Schiano TD, Lissoos TW, et al. Successful combined liverheart transplantation in adults: report of three patients and review of the literature. Transplantation 1999;68:1423.
10. Barreiros AP, Post F, Hoppe-Lotichius M, et al. Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience. Liver Transpl 2010;16:314.
11. Raichlin E, Daly RC, Rosen CB, et al. Combined heart and liver transplantation: a single-center experience. Transplantation 2009;88:219.
12. Daly RC, Topilsky Y, Joyce L, et al. Combined heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantation. Transplantation 2013;95:e2.
13. Porrett PM, Desai SS, Timmins KJ, et al. Combined orthotopic heart and liver transplantation: the need for exception status listing. Liver Transpl 2004;10:1539.
14. Manez R, Kelly RH, Kobayashi M, et al. Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance. Hepatology 1995;21:1345.
15. McMillan RW, Gelder FB, Zibari GB, et al. Soluble fraction of class I human histocompatibility leukocyte antigens in the serum of liver transplant recipients. Clin Transplant 1997;11:98.
16. Starzl TE, Valdivia LA, Murase N, et al. The biological basis of and strategies for clinical xenotransplantation. Immunol Rev 1994;141:213.
17. DarW, Agarwal A, Watkins C, et al. Donor-directed MHC class I antibody is preferentially cleared fromsensitized recipients of combined liver/kidney transplants. Am J Transplant 2011;11:841.
18. Taner T, Gandhi MJ, Sanderson SO, et al. Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant 2012;12:1504.
19. Colvin RB. C4d in liver allografts: a sign of antibody-mediated rejection? Am J Transplant 2006;6:447.
20. Olausson M, Mjornstedt L, Norden G, et al. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant 2007;7:130.
21. Bernier PL, Grenon M, Ergina P, et al. Combined simultaneous heart and liver transplantation with complete cardiopulmonary bypass support. Ann Thorac Surg 2007;83:1544.
22. Rauchfuss F, Breuer M, Dittmar Y, et al. Implantation of the liver during reperfusion of the heart in combined heart-liver transplantation: own experience and review of the literature. Transplant Proc 2011;43:2707.
23. Jovine E, Mazziotti A, Grazi GL, et al. Piggy-back versus conventional technique in liver transplantation: report of a randomized trial. Transpl Int 1997;10:109.
24. Fonouni H, Mehrabi A, Soleimani M, et al. The need for venovenous bypass in liver transplantation. HPB (Oxford) 2008;10:196.
25. Gurusamy KS, Koti R, Pamecha V, et al. Veno-venous bypass versus none for liver transplantation. Cochrane Database Syst Rev 2011;10: CD007712.
26. Nuttall GA, OliverWC, Santrach PJ, et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001;94:773.